| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cupric ion binding | 3.51e-05 | 5 | 38 | 2 | GO:1903135 | |
| GeneOntologyMolecularFunction | cholesterol binding | 1.83e-04 | 58 | 38 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | sterol binding | 3.32e-04 | 71 | 38 | 3 | GO:0032934 | |
| GeneOntologyMolecularFunction | alcohol binding | 9.59e-04 | 102 | 38 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | steroid binding | 2.06e-03 | 133 | 38 | 3 | GO:0005496 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.28e-03 | 138 | 38 | 3 | GO:0016614 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.68e-04 | 59 | 38 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | vacuole | 1.95e-04 | 913 | 38 | 8 | GO:0005773 | |
| GeneOntologyCellularComponent | vacuolar lumen | 2.99e-04 | 178 | 38 | 4 | GO:0005775 | |
| GeneOntologyCellularComponent | lysosome | 5.68e-04 | 811 | 38 | 7 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 5.68e-04 | 811 | 38 | 7 | GO:0000323 | |
| GeneOntologyCellularComponent | platelet dense granule | 6.61e-04 | 21 | 38 | 2 | GO:0042827 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.27e-03 | 29 | 38 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | autophagosome | 1.31e-03 | 119 | 38 | 3 | GO:0005776 | |
| GeneOntologyCellularComponent | integrin complex | 1.54e-03 | 32 | 38 | 2 | GO:0008305 | |
| GeneOntologyCellularComponent | cell surface | 3.49e-03 | 1111 | 38 | 7 | GO:0009986 | |
| Domain | Integrin_alpha | 2.19e-04 | 11 | 38 | 2 | PF00357 | |
| Domain | Oxysterol-bd | 2.63e-04 | 12 | 38 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 2.63e-04 | 12 | 38 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 2.63e-04 | 12 | 38 | 2 | PF01237 | |
| Domain | OSBP | 2.63e-04 | 12 | 38 | 2 | PS01013 | |
| Domain | Integrin_alpha_C_CS | 4.75e-04 | 16 | 38 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 6.04e-04 | 18 | 38 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 6.04e-04 | 18 | 38 | 2 | PF08441 | |
| Domain | Integrin_alpha | 6.04e-04 | 18 | 38 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 6.04e-04 | 18 | 38 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 6.74e-04 | 19 | 38 | 2 | IPR013519 | |
| Domain | Int_alpha | 6.74e-04 | 19 | 38 | 2 | SM00191 | |
| Domain | FG_GAP | 9.08e-04 | 22 | 38 | 2 | PS51470 | |
| Domain | FG-GAP | 1.08e-03 | 24 | 38 | 2 | PF01839 | |
| Domain | FG-GAP | 1.08e-03 | 24 | 38 | 2 | IPR013517 | |
| Domain | Integrin_dom | 1.17e-03 | 25 | 38 | 2 | IPR032695 | |
| Domain | - | 7.51e-03 | 64 | 38 | 2 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 1.13e-02 | 79 | 38 | 2 | IPR023214 | |
| Pubmed | 6.67e-07 | 16 | 38 | 3 | 15878328 | ||
| Pubmed | Complement protein C3 exacerbates prion disease in a mouse model of chronic wasting disease. | 1.16e-06 | 2 | 38 | 2 | 24038599 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22648512 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 14593528 | ||
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 3.87e-06 | 28 | 38 | 3 | 21335239 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.47e-06 | 1201 | 38 | 9 | 35696571 | |
| Pubmed | Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. | 1.16e-05 | 5 | 38 | 2 | 17947689 | |
| Pubmed | Integrins are required for the differentiation of visceral endoderm. | 2.43e-05 | 7 | 38 | 2 | 19118216 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 15006356 | ||
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 17428193 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 11483621 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 7.62e-05 | 12 | 38 | 2 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 7.62e-05 | 12 | 38 | 2 | 12215260 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 21665990 | ||
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 11564885 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 1.38e-04 | 16 | 38 | 2 | 12904471 | |
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 16439479 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.44e-04 | 1451 | 38 | 8 | 30550785 | |
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 12571105 | ||
| Pubmed | ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. | 1.96e-04 | 19 | 38 | 2 | 26116176 | |
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 9070936 | ||
| Pubmed | 2.18e-04 | 20 | 38 | 2 | 22687584 | ||
| Pubmed | Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. | 2.90e-04 | 23 | 38 | 2 | 23386589 | |
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 2.90e-04 | 23 | 38 | 2 | 23152823 | |
| Pubmed | Identification of proteins that interact with alpha A-crystallin using a human proteome microarray. | 2.95e-04 | 118 | 38 | 3 | 24453475 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 3.47e-04 | 307 | 38 | 4 | 37499664 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 4.01e-04 | 27 | 38 | 2 | 31541017 | |
| Pubmed | 4.63e-04 | 29 | 38 | 2 | 8617512 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 4.96e-04 | 30 | 38 | 2 | 36305473 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 5.32e-04 | 344 | 38 | 4 | 30333137 | |
| Pubmed | 5.65e-04 | 32 | 38 | 2 | 23154389 | ||
| Pubmed | 7.15e-04 | 36 | 38 | 2 | 15800025 | ||
| Pubmed | 7.56e-04 | 37 | 38 | 2 | 16319116 | ||
| Pubmed | 8.83e-04 | 40 | 38 | 2 | 18051367 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 9.94e-04 | 1070 | 38 | 6 | 23533145 | |
| Pubmed | A gene expression resource generated by genome-wide lacZ profiling in the mouse. | 1.07e-03 | 44 | 38 | 2 | 26398943 | |
| Interaction | FBXO2 interactions | 8.46e-06 | 411 | 37 | 7 | int:FBXO2 | |
| Interaction | TNC interactions | 2.72e-05 | 32 | 37 | 3 | int:TNC | |
| Interaction | LY86 interactions | 4.55e-05 | 217 | 37 | 5 | int:LY86 | |
| Cytoband | 14q24.3 | 2.72e-03 | 93 | 38 | 2 | 14q24.3 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.86e-04 | 12 | 31 | 2 | 670 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.28e-04 | 18 | 31 | 2 | 1160 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP | 6.54e-06 | 183 | 38 | 5 | M7631 | |
| Coexpression | COLINA_TARGETS_OF_4EBP1_AND_4EBP2 | 1.21e-05 | 359 | 38 | 6 | M1919 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.14e-07 | 186 | 38 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 187 | 38 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-07 | 199 | 38 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 7.18e-07 | 199 | 38 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.18e-07 | 199 | 38 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Club-club-13|World / Class top | 1.09e-05 | 162 | 38 | 4 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 174 | 38 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 179 | 38 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 180 | 38 | 4 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 183 | 38 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 184 | 38 | 4 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 184 | 38 | 4 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 185 | 38 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 185 | 38 | 4 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.87e-05 | 186 | 38 | 4 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 186 | 38 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 186 | 38 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 188 | 38 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 188 | 38 | 4 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-05 | 188 | 38 | 4 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 188 | 38 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 189 | 38 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 190 | 38 | 4 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | PND14-Epithelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-05 | 190 | 38 | 4 | f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 190 | 38 | 4 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 190 | 38 | 4 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 192 | 38 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 193 | 38 | 4 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 38 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 38 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 38 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.44e-05 | 199 | 38 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.48e-05 | 200 | 38 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.48e-05 | 200 | 38 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.48e-05 | 200 | 38 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Slc17a8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.07e-05 | 94 | 38 | 3 | 0dc7e645149fa4255cbe1d288524a1ca7ab66376 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 108 | 38 | 3 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 108 | 38 | 3 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 116 | 38 | 3 | 1bfd3b0ec4cb5a04c6dfe7861a544eb277e473a3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Reln_(Cajal-Retzius)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 116 | 38 | 3 | a3dcd18807d14e207438f321be62797384fd3907 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 116 | 38 | 3 | 685484ea4cbefb5aff5f0cd999fdfadc5a5676e1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 122 | 38 | 3 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | (09)_Ionocytes-(4)_1wkpi|(09)_Ionocytes / shred by cell type and Timepoint | 1.59e-04 | 22 | 38 | 2 | b35fb230042a027b10ef3e7ef09bf13ea1cdc506 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Mup5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-04 | 127 | 38 | 3 | 6df92f80b8922ca00eb383f79cd8dda4d602adfc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-04 | 127 | 38 | 3 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 130 | 38 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 135 | 38 | 3 | e908aacb72a8c340f06cf5b4a6b70c2faac4d027 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.30e-04 | 140 | 38 | 3 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 141 | 38 | 3 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 148 | 38 | 3 | 941bad657064b3d37cae8b66df99c1aa1098c088 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-04 | 153 | 38 | 3 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.04e-04 | 154 | 38 | 3 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 156 | 38 | 3 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.21e-04 | 157 | 38 | 3 | d4908cafd8870c1c225817f589ea2bce116ac7ab | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.34e-04 | 159 | 38 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-04 | 160 | 38 | 3 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-04 | 160 | 38 | 3 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.52e-04 | 162 | 38 | 3 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 165 | 38 | 3 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.72e-04 | 165 | 38 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-04 | 167 | 38 | 3 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.92e-04 | 168 | 38 | 3 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.99e-04 | 169 | 38 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 170 | 38 | 3 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-04 | 170 | 38 | 3 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.13e-04 | 171 | 38 | 3 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.13e-04 | 171 | 38 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-04 | 172 | 38 | 3 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-2_PAX6_SCGN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-04 | 173 | 38 | 3 | 33170a1cc0bc87504d0501fc257a32ff17e02314 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.27e-04 | 173 | 38 | 3 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 174 | 38 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.41e-04 | 175 | 38 | 3 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.49e-04 | 176 | 38 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 4.56e-04 | 177 | 38 | 3 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 178 | 38 | 3 | 08b4a497aca0aeabf4f6a8a55c05b56417b69e78 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 178 | 38 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_LGI2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 179 | 38 | 3 | 8dd10e3a9ab39d9a770cecac6e2ed3676b79e906 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.72e-04 | 179 | 38 | 3 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 179 | 38 | 3 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-04 | 179 | 38 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 180 | 38 | 3 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.79e-04 | 180 | 38 | 3 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 180 | 38 | 3 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 180 | 38 | 3 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| Disease | colon cancer (biomarker_via_orthology) | 1.16e-03 | 39 | 38 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | sex interaction measurement, inflammatory bowel disease | 2.30e-03 | 55 | 38 | 2 | EFO_0003767, EFO_0008343 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSGVTIQIMRASEYY | 136 | P41238 | |
| ASQVMRYADLYAASF | 451 | P49902 | |
| MNLQRSYTVAIAGYA | 1181 | P01024 | |
| MANYYEVLGVQASAS | 1 | Q8NHS0 | |
| QYMATADRSFTVAVY | 706 | Q8TBY9 | |
| YIRMAASLNAGETTY | 296 | Q9H1K0 | |
| RAMLAGATAVYSQFI | 656 | Q92878 | |
| MAFYSYNSVLAIART | 1 | Q2VYF4 | |
| AARYGAATANYMEVV | 236 | P43304 | |
| LYEMTVRNASTAVYA | 646 | Q9NQG7 | |
| TDGMASVAAYTYRQH | 411 | P51805 | |
| LAQYRISMAAYVSGE | 751 | P17858 | |
| YVVMNHGRSYTAIST | 461 | P14543 | |
| AGAFYRSYTTQLTMN | 221 | Q96A46 | |
| AAMAAAAATTSSYYG | 286 | Q9BQ04 | |
| QMASYFGYTVVVSDV | 316 | P53708 | |
| MDSVALNTAYAYATV | 126 | O15439 | |
| IRSLYNFSGEQMASY | 311 | P08648 | |
| QMASYFGYAVAATDV | 321 | P08648 | |
| AQVASGMAYLESRNY | 336 | P42685 | |
| MLQSYTAAGYRVVAL | 676 | Q9NQ11 | |
| AVAVTESYVYVAGSM | 401 | Q9NVR0 | |
| VAMVSYNSGTSYLIR | 1801 | A8TX70 | |
| GGSISNMYAVNLARY | 151 | Q9Y600 | |
| QESMRAYAANVYTSV | 46 | Q9Y2E5 | |
| TGYTAYMVSVAAFNA | 1691 | Q58EX2 | |
| RMVYVAAFAISAYAS | 581 | Q9H4L5 | |
| ERMVYIAAFAVSAYS | 531 | Q9BZF2 | |
| YVAVVVALAAYMSQN | 221 | A6NDD5 | |
| VVAAAYGCIYASLMA | 326 | Q8N967 | |
| FANAVAVAMYVVGFA | 266 | Q13621 | |
| MSAAAAAAAVVAYGR | 401 | Q04724 | |
| ACLYSMVAGVAYISA | 136 | Q8N966 | |
| AYSAYASFAVVIMVT | 601 | Q9NXL6 | |
| ESQAYYQRGSSMVLF | 221 | P04156 | |
| AFTYAVSAAGVVNAM | 136 | P41221 | |
| ASARYTVGQAVAYMA | 111 | Q8N4Q0 | |
| VFYYARRSNMSGAVQ | 551 | O15321 | |
| GKTVSARYAMRYFAT | 166 | Q9NQX4 | |
| ARYAMRYFATVSKSG | 171 | Q9NQX4 |